32 related articles for article (PubMed ID: 16004889)
1. Conduction Slowing: Association or Causation in Atrial Fibrillation.
Lee S; Sahadevan J
JACC Clin Electrophysiol; 2020 Dec; 6(14):1855-1857. PubMed ID: 33357583
[No Abstract] [Full Text] [Related]
2. How should we treat high-normal blood pressure and pre-atrial fibrillation?
Kabutoya T; Kario K
Hypertens Res; 2024 May; ():. PubMed ID: 38789540
[No Abstract] [Full Text] [Related]
3. Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population.
Holmqvist F; Platonov PG; Carlson J; Havmöller R; Waktare JE; McKenna WJ; Olsson SB; Meurling CJ
Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):227-36. PubMed ID: 17617068
[TBL] [Abstract][Full Text] [Related]
4. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
5. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension.
Hennersdorf MG; Schueller PO; Steiner S; Strauer BE
Hypertens Res; 2007 Jun; 30(6):535-40. PubMed ID: 17664857
[TBL] [Abstract][Full Text] [Related]
7. Validation of inter-atrial conduction time measurement by means of echo-Doppler.
Fuenmayor AJ; Ramírez L; Fuenmayor AM
Arch Cardiol Mex; 2002; 72(2):125-8. PubMed ID: 12148331
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
9. Inter-atrial conduction time shortens after blood pressure control in hypertensive patients with left ventricular hypertrophy.
Fuenmayor AJ; Moreno G; Landaeta A; Fuenmayor AM
Int J Cardiol; 2005 Jul; 102(3):443-6. PubMed ID: 16004889
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
11. [Pathological modifications of the P wave due to probable primary changes in intra-atrial conduction].
Catalano F; Perugini A; Giovannelli E; Nisii M
Minerva Med; 1991 Apr; 82(4):171-5. PubMed ID: 2017312
[TBL] [Abstract][Full Text] [Related]
12. [Hypertensive cardiopathy and arrhythmias].
López Gil M; Arribas F; Velázquez MT; Casas P
Rev Esp Cardiol; 1997; 50 Suppl 4():68-73. PubMed ID: 9411591
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]